arbekacin has been researched along with Sepsis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukuda, Y; Hashiguchi, K; Imamura, Y; Inoue, Y; Izumikawa, K; Kakeya, H; Kobayashi, T; Kohno, S; Kondo, A; Miyazaki, T; Morinaga, Y; Nakamura, S; Yamamoto, Y; Yanagihara, K | 1 |
Akiyama, N; Arai, T; Hanaki, H; Higashihara, M; Ichiwata, T; Ikegami, K; Kimura, T; Kobayashi, M; Matsumoto, T; Miyao, N; Nemoto, M; Oda, S; Ohyashiki, K; Otsuka, Y; Soma, K; Sunakawa, K; Suzuki, Y; Totsuka, K; Yokota, H; Yoshida, M; Yukioka, T | 1 |
Aikawa, N; Kaku, M; Morita, K; Sato, R; Shimizu, K; Tanigawara, Y | 1 |
Aihara, Y; Fukamachi, K; Hori, T; Imamura, T; Kasuya, H; Kawashima, A; Kikuchi, K; Ochiai, T; Shiseki, M; Tozuka, K; Yamaguchi, K | 1 |
Arakawa, M; kawashima, T; Tsukasa, H; Wada, K | 1 |
Bouanchaud, DH; Rolin, O | 1 |
1 trial(s) available for arbekacin and Sepsis
Article | Year |
---|---|
The efficacy and safety of high-dose arbekacin sulfate therapy (once-daily treatment) in patients with MRSA infection.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Dibekacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Sepsis; Staphylococcal Infections; Treatment Outcome | 2012 |
5 other study(ies) available for arbekacin and Sepsis
Article | Year |
---|---|
Clinical efficacy and safety of arbekacin sulfate in patients with MRSA sepsis or pneumonia: a multi-institutional study.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Dibekacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Japan; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Sepsis | 2013 |
Population pharmacokinetics of Arbekacin in patients infected with methicillin-resistant Staphylococcus aureus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Aminoglycosides; Anti-Bacterial Agents; Child; Dibekacin; Dose-Response Relationship, Drug; Female; Humans; Male; Methicillin Resistance; Middle Aged; Models, Statistical; Population; Reproducibility of Results; Sepsis; Staphylococcal Infections | 2006 |
[Two cases of methicillin-resistant Staphylococcus aureus (MRSA) sepsis following craniotomy].
Topics: Adult; Aged; Alanine; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Craniotomy; Dibekacin; Drug Therapy, Combination; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Methicillin Resistance; Postoperative Complications; Sepsis; Staphylococcal Infections; Sulbactam; Thienamycins; Treatment Outcome; Vancomycin | 2000 |
[Septicemia caused by MRSA].
Topics: Aminoglycosides; Anti-Bacterial Agents; Catheterization; Dibekacin; Equipment Contamination; Humans; Methicillin Resistance; Prognosis; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
Protective activity of habekacin and four other aminoglycosides in mouse septicaemia caused by Enterobacteriaceae.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Enterobacteriaceae Infections; Female; Gentamicins; Kanamycin; Male; Mice; Microbial Sensitivity Tests; Sepsis; Tobramycin | 1986 |